| |
Newsroom /
Medical
/
Medical
/
Elder Pharma Board Recommends 30% Dividend For 2009-10
Elder Pharma Board Recommends 30% Dividend For 2009-10
The Rs 720 crore, Mumbai headquartered Elder Pharmaceuticals Ltd, one of the fastest growing Domestic Pharmaceutical Companies has recommended a dividend of 30% for the year 2009-10.
Mumbai,
Maharashtra,
India
(prbd.net)
21/08/2010
"The Rs 720 crore, Mumbai headquartered Elder Pharmaceuticals Ltd, one of the fastest growing Domestic Pharmaceutical Companies has recommended a dividend of 30% for the year 2009-10."
The Rs 720 crore, Mumbai headquartered Elder Pharmaceuticals Ltd, one of the fastest growing Domestic Pharmaceutical Companies has recommended a dividend of 30% for the year 2009-10 (ending 31st March 2010) and finalized the audited results at a board meeting held on August 18, 2010. During the financial year ended March 2010, the consolidated Income from Operations stood at Rs. 720.87 Crore (previous year 2008-09 - Rs. 619.72 Crore), registering a growth of 16%. Consolidated Net Profit for the period stood at Rs. 49.82 Crore. The EPS for FY2010 stood to Re 26.42.
For the first quarter ended June 2010 (Q1 FY2011), the consolidated Income from Operations increased by 19% and stood at Rs 194.30 Crore as compared to Rs. 162.90 Crore during the corresponding quarter in the previous year. The consolidated operating profit (PBIDT) too has gone up to Rs 37.77 Crore for Q1 FY2011 reflecting a growth of 40% over the previous corresponding quarter’s figure of Rs 26.97 Crore. The consolidated Net Profit too has gone up to Rs 16.68 Crore (previous year’s quarter - Rs 11.48 Crore) - a jump of 45%.
Elder Pharmaceuticals ( http://www.elderindia.com ) has presence in niche therapeutic segments like Women’s Healthcare, Wound care and Pain Management, Nutraceuticals, Anti-Infective and Lifestyle Disease Care. It is the market leaders in calcium supplement (Shelcal), wound healing (Chymoral) and injectible vitamin B12 (Eldervit). The company has a judicious mix of drug formulations, in-licensed manufacturing and APIs. It has 6 manufacturing plants in India located in Maharashtra, Uttarakhand & Himachal Pradesh. The company has a state-of-the-art Research & Development Centre at Navi Mumbai which is recognized by the Department of Scientific & Industrial Research, Ministry of Science & Technology. (http://www.elderindia.com).
Press Contact:
Mitesh M Kapadia
Sentinel Public Relations Pvt Ltd / Sentinel Advertising Services
B-603, Samajdeep,
Near Bhanu Park/Seasons Restaurant
Adukia Road, Off S V Road
Kandivli (W), Mumbai 400 067. INDIA
Tel: (91 22) 28625131/32. Cel: +91 98205 03876
Fax: (91 22) 28625133
mitesh@publicrelationindia.com
http://www.publicrelationindia.com
http://www.elderindia.com
About
The Rs 700 crore Elder Pharmaceuticals Limited is headquartered in Mumbai, India and has presence in niche therapeutic segments like Women’s healthcare, Wound care, Nutraceuticals /vitamin Supplements, Cardiology, Diabetes, Dermatology, Antibiotics and CNS.
|